Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2017 · 10-Q
Revenue$467.00K$467.00K−36.1% vs Q3 2016 Net Income-$4.81M-$4.81MN/M vs Q3 2016 EPS Diluted-$1.39-$1.39N/M vs Q3 2016 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,049,000N/M Free Cash Flowderived-$4,225,000N/M Margins · derivedGross margin-4.3%−19.7 pt vs Q3 2016
Operating margin-930.0%−273.8 pt vs Q3 2016
Net margin-1029.3%−292.8 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 9, 2017 · 40 d after period end